Evaluation of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis: A Single Center Experience

Autor: Pia Elkjær Høeg, Mia Glerup, Birgitte Mahler, Christian Høst, Troels Herlin

Publikováno v: International Journal of Rheumatology, Vol 2022 (2022)

Objectives. Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile arthritis (sJIA), and early diagnosis is critical for survival. The objective of this study was to evaluate the 2016 MAS classification criteria in a Danis

Externí odkaz: https://doaj.org/article/425970e3442b44248e2864331a8bcb19

Eliciting Information Needs of Child Patients: Adapting the Kano Model to the Design of mHealth Applications

Autor: Sune Dueholm Müller, Georgios Tsirozidis, Morten Mathiasen, Louise Nordenhof, Daniel Jakobsen, Birgitte Mahler

Publikováno v: Methods of information in medicine. 61(3-04)

Background Health care services are increasingly being digitized, but extant literature shows that digital technologies and applications are often developed without careful consideration of user needs. Research is needed to identify and investigate b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d2fcc01bbb5418064c435804d75c95
https://pubmed.ncbi.nlm.nih.gov/36220108

Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation

Autor: Mette Christiansen, Troels Herlin, Trine H. Mogensen, Sofie E. Jørgensen, Mira M Lausten, Mia Glerup, Rune Hartmann, Birgitte Mahler, Christian Høst, Hans Henrik Gad

Publikováno v: Jørgensen, S E, Christiansen, M, Høst, C, Glerup, M, Mahler, B, Lausten, M M, Gad, H H, Hartmann, R, Herlin, T & Mogensen, T H 2020, ' Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation ', Rheumatology (Oxford, England), vol. 59, no. 10 . https://doi.org/10.1093/rheumatology/keaa242

ObjectivesWe investigated a patient with systemic juvenile idiopathic arthritis (sJIA) and recurrent macrophage activation syndrome (MAS) to discover genetic and immunological contributing factors.MethodsSevere recurrent MAS motivated whole exome seq

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7e1428e76c56736980e09e2d5b1dff
https://pure.au.dk/portal/da/publications/systemic-juvenile-idiopathic-arthritis-and-recurrent-macrophage-activation-syndrome-due-to-a-casp1-variant-causing-inflammasome-hyperactivation(e67625d4-e314-41e4-aab1-a18bac515761).html

Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease

Autor: Rita De Vito, Anna Alisi, Søren Rittig, Henning Grønbæk, Konstantin Kazankov, Birgitte Mahler, Valerio Nobili, Holger Jon Møller

Publikováno v: Kazankov, K, Alisi, A, Møller, H J, De Vito, R, Rittig, S, Mahler, B, Nobili, V & Grønbæk, H 2018, ' Macrophage Markers are Poorly Associated with Liver Histology in Children with Non-Alcoholic Fatty Liver Disease ', Journal of Pediatric Gastroenterology and Nutrition, vol. 67, no. 5, pp. 635–642 . https://doi.org/10.1097/MPG.0000000000002111

OBJECTIVES: We have previously demonstrated associations between the macrophage activation marker soluble (s)CD163 and histology of non-alcoholic fatty liver disease (NAFLD) in adults, and elevated sCD163 levels in obese children with NAFLD. However,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f3a3bb17cdca241f0ba6385babc79e
https://doi.org/10.1097/mpg.0000000000002111

Determination of the renal concentration capacity following intravenous administration of dDAVP in healthy humans

Autor: Marie K. Schroeder, Birgitte Mahler, Jane H. Christensen, Søren Rittig, Mia Faerch, Konstantinos Kamperis

Publikováno v: Faerch, M, Schroeder, M K, Mahler, B T, Christensen, J H, Kamperis, K & Rittig, S 2018, ' Determination of the renal concentration capacity following intravenous administration of dDAVP in healthy humans ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 1-2, pp. 114-119 . https://doi.org/10.1080/00365513.2017.1420215

The synthetic AVP analogue 1-desamino-8-d-arginine-vasopressin (dDAVP) is used for treatment of polyuric disorders. Lack of commercially available assays limits the usefulness of dDAVP as a diagnostic tool in the assessment of renal concentrating cap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7526b7e00d92820f20729db688a444
https://pubmed.ncbi.nlm.nih.gov/29361858